Unplanned Return to the Operating Room after Elective Oncologic Thoracic Surgery: A Further Quality Indicator in Surgical Oncology.

adverse events complications morbidity mortality operating room thoracic oncology unplanned return

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
20 Apr 2022
Historique:
received: 20 03 2022
revised: 13 04 2022
accepted: 18 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 15 5 2022
Statut: epublish

Résumé

Background: An unplanned return to the operating room (UROR) is defined as a readmission to the operating room because of a complication or an untoward outcome related to the initial surgery. The aim of the present report is to evaluate the role of URORs after elective oncologic thoracic surgery. Methods: In the study, 4012 consecutive patients were enrolled; among them, 71 patients (1.76%) had an unplanned return to the operating room. Age, sex, Charlson comorbidity index, induction treatments, type of the first operation, indication to readmission to the operating room and type of second operation, length of stay, complication after reoperation and outcomes were collected. Results: The mean age was 63.3 (SD: 13.0); there were 53 male patients (74.6%); the type of the first procedure was: lower lobectomy (11.3%), middle lobectomy (1.4%), upper lobectomy (22.5%), metastasectomy (5.6%), extrapleural pneumonectomy (4.2%), pneumonectomy (40.9%), pleural biopsy (5.6%) and other procedures (8.5%). Patients presenting complications after UROR had undergone a significantly longer first procedure (p < 0.02), had a longer length of stay (p < 0.001) and had higher post-operative mortality (p < 0.001). Conclusions: The patients experiencing UROR after elective oncologic thoracic surgery have significantly higher morbidity and mortality rates when compared to standard thoracic surgery. Bronchopleural fistula remains the most lethal complication in patients undergoing UROR.

Identifiants

pubmed: 35565193
pii: cancers14092064
doi: 10.3390/cancers14092064
pmc: PMC9104285
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : 5 x mille
ID : 0000 Ministry of health

Références

N Engl J Med. 2007 Feb 1;356(5):486-96
pubmed: 17259444
JAMA Surg. 2014 May;149(5):467-74
pubmed: 24623045
Medicine (Baltimore). 2021 Dec 10;100(49):e28053
pubmed: 34889250
Eur J Surg. 1999 May;165(5):421-4; discussion 425
pubmed: 10391156
J Gastrointest Surg. 2017 Jun;21(6):1048-1054
pubmed: 28342119
Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):104-113
pubmed: 29109057
Health Serv Res. 2012 Oct;47(5):1861-79
pubmed: 22985030
J Vasc Surg. 1987 Aug;6(2):134-8
pubmed: 3612962
Am J Med Qual. 2007 May-Jun;22(3):198-202
pubmed: 17485561
Eur J Obstet Gynecol Reprod Biol. 2011 Aug;157(2):222-5
pubmed: 21507554
JAMA. 2004 Aug 18;292(7):847-51
pubmed: 15315999
Arch Surg. 2001 Apr;136(4):405-11
pubmed: 11296110
J Am Coll Surg. 2010 Jan;210(1):6-16
pubmed: 20123325
J Surg Res. 2013 Jun 1;182(1):11-6
pubmed: 22921919
Eur J Anaesthesiol. 2011 Jan;28(1):10-5
pubmed: 21166109
Ann Thorac Surg. 2014 Feb;97(2):480-3
pubmed: 24370201
Br J Surg. 2003 May;90(5):527-32
pubmed: 12734856
J Am Coll Surg. 1995 May;180(5):519-31
pubmed: 7749526
N Engl J Med. 1991 Feb 7;324(6):370-6
pubmed: 1987460
J Am Coll Surg. 2008 Nov;207(5):777-82
pubmed: 18954793
J Thorac Dis. 2020 Dec;12(12):7266-7271
pubmed: 33447415
Aust N Z J Surg. 1996 Jan;66(1):10-3
pubmed: 8629971
Ann Vasc Surg. 2003 Mar;17(2):198-202
pubmed: 12616358
Stat Med. 1995 Oct 15;14(19):2161-72
pubmed: 8552894
Surg Infect (Larchmt). 2006 Jun;7(3):263-8
pubmed: 16875459
Children (Basel). 2022 Jan 13;9(1):
pubmed: 35053730
Am J Manag Care. 2008 Dec;14(12):833-8
pubmed: 19067500
Arch Surg. 2002 May;137(5):611-7; discussion 617-8
pubmed: 11982478
Am J Surg. 2017 Jul;214(1):1-6
pubmed: 28057294
N Engl J Med. 1991 Feb 7;324(6):377-84
pubmed: 1824793

Auteurs

Francesco Petrella (F)

Department of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, 20122 Milan, Italy.

Monica Casiraghi (M)

Department of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.

Davide Radice (D)

Division of Epidemiology and Biostatistics, IRCCS European Institute of Oncology, 20141 Milan, Italy.

Claudia Bardoni (C)

Department of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.

Andrea Cara (A)

Department of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.

Shehab Mohamed (S)

Department of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.

Daniele Sances (D)

Division of Anesthesiology, IRCCS European Institute of Oncology, 20141 Milan, Italy.

Lorenzo Spaggiari (L)

Department of Thoracic Surgery, IRCCS European Institute of Oncology, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, 20122 Milan, Italy.

Classifications MeSH